Patent details

EP2628489 Title: PEG oligomer-fentanyl conjugates

Basic Information

Publication number:
EP2628489
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP131675191
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PEG oligomer-fentanyl conjugates
French Title of Invention:
Conjugués de PEG oligomère-fentanyl
German Title of Invention:
PEG Oligomer-Fentanyl-Konjugate
SPC Number:

Dates

Filing date:
21/07/2010
Grant date:
01/03/2017
EP Publication Date:
21/08/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/03/2017
EP B1 Publication Date:
01/03/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/07/2017
Expiration date:
21/07/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/03/2017
 
 

Name:
Nektar Therapeutics
Address:
455 Mission Bay Boulevard South, San Francisco, CA 94158, United States (US)

Inventor

1

Name:
Riley, Timothy A.
Address:
United States (US)

2

Name:
Deng, Bo-Liang
Address:
United States (US)

3

Name:
Riggs-Sauthier, Jennifer
Address:
United States (US)

Priority

1

Priority Number:
227399 P
Priority Date:
21/07/2009
Priority Country:
United States (US)

2

Priority Number:
558395
Priority Date:
11/09/2009
Priority Country:
United States (US)

3

Priority Number:
350853 P
Priority Date:
02/06/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 47/60;

Publication

European Patent Bulletin

Issue number:
201709
Publication date:
01/03/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/11/2017 Outgoing Correspondence 1